Literature DB >> 1846795

Limits of brain tolerance to daily increments in serum sodium in chronically hyponatraemic rats treated with hypertonic saline or urea: advantages of urea.

A Soupart1, A Stenuit, O Perier, G Decaux.   

Abstract

1. At present there is no consensus about the optimal management of hyponatraemia to prevent demyelinating brain lesions. We have evaluated in a large series of rats (n = 136) the protective role of urea for the brain in the treatment of severe chronic hyponatraemia. Urea (group I, n = 51) was compared with hypertonic saline in boluses (group II, n = 46) and with hypertonic saline in divided doses (group III, n = 39). Treatment was administered intraperitoneally over 48 h. The severity of brain lesions was assessed by histological scoring. 2. For 95% of the injured animals treated with hypertonic saline, brain lesions appeared for an absolute increment in serum Na+ concentration (delta SNa+) of 20 mmol day-1 l-1. Above this limit neurological injuries gradually worsened, and beyond a transition zone (delta SNa+ greater than or equal to 20 less than or equal to 23 mmol day-1 l-1) 89% (group III) to 100% (group II) of the animals were injured. This limit can be reached rapidly, as attested by the comparable severity of brain lesions observed in group II (mean delta SNa+ 1 h after a bolus injection, 19 mmol/l) and in group III (mean delta SNa+ 1 h after an injection, 2 mmol/l), both groups achieving similar daily delta SNa+. 3. A correction above the threshold of 20 mmol day-1 l-1 is as toxic during the first 24 h as during the second day of the treatment.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1846795     DOI: 10.1042/cs0800077

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  9 in total

1.  Astrocytes are an early target in osmotic demyelination syndrome.

Authors:  Fabrice Gankam Kengne; Charles Nicaise; Alain Soupart; Alain Boom; Johan Schiettecatte; Roland Pochet; Jean Pierre Brion; Guy Decaux
Journal:  J Am Soc Nephrol       Date:  2011-09-01       Impact factor: 10.121

2.  Minocycline protects against neurologic complications of rapid correction of hyponatremia.

Authors:  Fabrice Gankam-Kengne; Alain Soupart; Roland Pochet; Jean Pierre Brion; Guy Decaux
Journal:  J Am Soc Nephrol       Date:  2010-11-04       Impact factor: 10.121

3.  Osmotic myelinolysis following chronic hyponatremia corrected at an overall rate consistent with current recommendations.

Authors:  Casey Dellabarca; Karen S Servilla; Blaine Hart; Glen H Murata; Antonios H Tzamaloukas
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

Review 4.  Therapeutic Relowering of Plasma Sodium after Overly Rapid Correction of Hyponatremia: What Is the Evidence?

Authors:  Helbert Rondon-Berrios
Journal:  Clin J Am Soc Nephrol       Date:  2019-10-10       Impact factor: 8.237

Review 5.  Cell volume regulation: a review of cerebral adaptive mechanisms and implications for clinical treatment of osmolal disturbances: II.

Authors:  H Trachtman
Journal:  Pediatr Nephrol       Date:  1992-01       Impact factor: 3.714

6.  Human cerebral osmolytes during chronic hyponatremia. A proton magnetic resonance spectroscopy study.

Authors:  J S Videen; T Michaelis; P Pinto; B D Ross
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

7.  Treatment of euvolemic hyponatremia in the intensive care unit by urea.

Authors:  Guy Decaux; Caroline Andres; Fabrice Gankam Kengne; Alain Soupart
Journal:  Crit Care       Date:  2010-10-14       Impact factor: 9.097

Review 8.  Hypertonicity: Clinical entities, manifestations and treatment.

Authors:  Helbert Rondon-Berrios; Christos Argyropoulos; Todd S Ing; Dominic S Raj; Deepak Malhotra; Emmanuel I Agaba; Mark Rohrscheib; Zeid J Khitan; Glen H Murata; Joseph I Shapiro; Antonios H Tzamaloukas
Journal:  World J Nephrol       Date:  2017-01-06

9.  Actual Therapeutic Indication of an Old Drug: Urea for Treatment of Severely Symptomatic and Mild Chronic Hyponatremia Related to SIADH.

Authors:  Guy Decaux; Fabrice Gankam Kengne; Bruno Couturier; Frédéric Vandergheynst; Wim Musch; Alain Soupart
Journal:  J Clin Med       Date:  2014-09-18       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.